| Literature DB >> 35269602 |
Hayoung Song1, Ju-Young Ahn2, Fanzhuang Yan2, Yidong Ran3, Okjae Koo4, Geung-Joo Lee1,2.
Abstract
We determined the specificity of mutations induced by the CRISPR-Cas9 gene-editing system in tobacco (Nicotiana benthamiana) alleles and subsequent genetic stability. For this, we prepared 248 mutant plants using an Agrobacterium-delivered CRISPR-Cas9 system targeting α-1,3-fucosyltransferase 1 (FucT1) and β-1,2-xylosyltransferase1 (XylT1) genes, for which the mutation rates were 22.5% and 25%, respectively, with 20.5% for both loci. Individuals with wild-type (WT) alleles at the NbFucT1 locus in T0 were further segregated into chimeric progeny (37-54%) in the next generation, whereas homozygous T0 mutants tended to produce more (~70%) homozygotes than other bi-allelic and chimeric progenies in the T1 generation. Approximately 81.8% and 77.4% of the homozygous and bi-allelic mutations in T0 generation, respectively, were stably inherited in the next generation, and approximately 50% of the Cas9-free mutants were segregated in T2 generation. One homozygous mutant (Ta 161-1) with a +1 bp insertion in NbFucT1 and a -4 bp deletion in NbXylT1 was found to produce T2 progenies with the same alleles, indicating no activity of the integrated Cas9 irrespective of the insertion or deletion type. Our results provide empirical evidence regarding the genetic inheritance of alleles at CRISPR-targeted loci in tobacco transformants and indicate the potential factors contributing to further mutagenesis.Entities:
Keywords: Cas9-free; Nicotiana benthamiana; allele heredity; multi-locus mutation; segregation ratio
Mesh:
Substances:
Year: 2022 PMID: 35269602 PMCID: PMC8910323 DOI: 10.3390/ijms23052450
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Transgenic tobacco plant production based on the application of CRISPR-Cas9-mediated gene editing. (A) Location of target sites in the NbFucT1 (Accession number: EF562630) and NbXylT1 (Accession Number: EF562628) genes and information on each gRNA sequence. Red and black boxes represent exons, and the sequence shown under exon 1 is that of gRNA. Nucleotides denoted in red are the PAM sequences. (B) Schematic diagram of a binary vector designed for simultaneous mutagenesis of the NbFucTI and NbXylT1 genes using CRISPR-Cas9. (C) Photographs depicting the stages of transgenic tobacco plant production. 1. Infection and cocultivation; 2 and 3. Shoot induction; 4 and 5. Shoot elongation; 6. Rooting.
Proportions of T0 plants with mutations in the target sequences.
| Target Gene | No. of Plants Examined | No. of Mutated Regenerants | Mutation Rate by Locus | ||||
|---|---|---|---|---|---|---|---|
|
|
| Both Loci |
|
| Both Loci | ||
|
| 248 | 56 | 62 | 51 | 22.5% | 25% | 20.56% |
|
| |||||||
Genotype and zygosity analysis of independent T0 transformants.
| Target Gene: | Target Gene: | |||||||
|---|---|---|---|---|---|---|---|---|
| Mutant | Detected Mutations | Mutation Type | Total | Ratio | Detected Mutations | Mutation Type | Total | Ratio |
| Ta75 | No mutation | Wild type | 3 | 17.6% | + 1bp/−1 bp | Bi-allele | 16 | 94.% |
| Ta139 | No mutation | Wild type | +1 bp/−1 bp | Bi-allele | ||||
| Ta158 | No mutation | Wild type | +1 bp/+1 bp | Bi-allele | ||||
| Ta3 | −9 bp/−9 bp | Homozygote | 9 | 52.9% | −11 bp/+1 bp | Bi-allele | ||
| Ta12 | −9 bp/−9 bp | Homozygote | −11 bp/+1 bp | Bi-allele | ||||
| Ta18 | −9 bp/−9 bp | Homozygote | −11 bp/+1 bp | Bi-allele | ||||
| Ta27 | −9 bp/−9 bp | Homozygote | −11 bp/+1 bp | Bi-allele | ||||
| Ta105 | +1 bp/+1 bp | Homozygote | +1 bp/+1 bp | Bi-allele | ||||
| Ta106 | +1 bp/+1 bp | Homozygote | +1 bp/+1 bp | Bi-allele | ||||
| Ta146 | −4 bp/−4 bp | Homozygote | +1 bp/+1 bp | Bi-allele | ||||
| Ta161 | −4 bp/−4 bp | Homozygote | +1 bp/+1 bp | Bi-allele | ||||
| Ta122 | −113 bp/−113 bp | Homozygote | +1 bp/+1 bp | Bi-allele | ||||
| Ta117 | +1 bp/−9 bp | Bi-allele | 5 | 29.4% | +1 bp/−9 bp | Bi-allele | ||
| Ta133 | +1 bp/−9 bp | Bi-allele | +1 bp/−9 bp | Bi-allele | ||||
| Ta237 | +1 bp/−4 bp | Bi-allele | +1 bp/−9 bp | Bi-allele | ||||
| Ta248 | +1 bp/+1 bp | Bi-allele | +1 bp/+1 bp | Bi-allele | ||||
| Ta77 | +1 bp/−4 bp | Bi-allele | No Mutation | Wild type | 1 | 5.8% | ||
Figure 2Selected examples of regenerated transgenic tobacco plants and their corresponding edited gene sequences. (A) Photographs of transgenic tobacco plants 2 weeks after transferring to soil. Plants were grown in pots and reached a height of 8.5 cm and a diameter of 9.5 cm at the top. Although some T0 plants showed shrunken appearances compared to the wild-type, in the case of T1 and T2 plants grown from seeds of the self-pollinated T0 and T1 plants, respectively, no phenotypic differences were found between the wild-type and mutated descendants. (B) Content and pattern of mutations in the targeted sequence. Nucleotides highlighted in yellow are PAM sequences, and underlined bases are gRNA sequences. The red letter indicates mutations in the target sequence. The + or − symbol in the target gene sequence represents base insertion or deletion compared to WT sequences, respectively. (C) Table of mutation information of transgenic plants. In the row of Cas9, a symbol + is for the presence of Cas9 in the mutants.
Genetic analysis of CRISPR-Cas9 induced mutations of NbFucT1 in the T0 generation and their transmission to the T1 generation.
| Target Gene: | ||||||
|---|---|---|---|---|---|---|
| T0 Generation | T1 Generation | |||||
| Plant ID | Zygosity (Detected Variation) | Plant ID | Zygosity | Detected Variation | No. of | Ratio |
| Ta75 | Wild type | Bi-allele | 0 | 0.0% | ||
| Homozygote | 0 | 0.0% | ||||
| 75-2, 75-12, | Chimera | +1 bp/−6 bp/−5 bp/−4 bp * | 4 | 36.4% | ||
| Wild type | No mutation | 5 | 45.5% | |||
| Ta139 | Wild type | Bi-allele | 0 | 0.0% | ||
| Homozygote | 0 | 0.0% | ||||
| 139-2, 139-16 | Chimera | +1 bp/−6 bp/WT/−5 bp/−4 bp * | 2 | 25.0% | ||
| Wild type | No mutation | 5 | 62.5% | |||
| Ta105 | Homozygote | 105-4 | Bi-allele | +1 bp(G)/ −1 bp * | 1 | 10.0% |
| Homozygote | +1 bp(T)/+1 bp(T) | 8 | 80.0% | |||
| 105-3 | +1 bp(G)/+1 bp(G) * | 1 | 10.0% | |||
| Chimera | 0 | 0.0% | ||||
| Wild type | No mutation | 0 | 0.0% | |||
| Ta106 | Homozygote | Bi-allele | 0 | 0.0% | ||
| Homozygote | + 1bp(T)/+1 bp(T) | 7 | 87.5% | |||
| 106-1 | Chimera | −5 bp/−2 bp/−4 bp/+1 bp * | 1 | 12.5% | ||
| Wild type | No mutation | 0 | 0.0% | |||
| Ta146 | Homozygote | 146-16 | Bi-allele | −4 bp/+1 bp(T) * | 1 | 10.0% |
| 146-1, 146-2, 146-11, 146-12, 146-13, 146-17, 146-18 | Homozygote | −4 bp/−4 bp | 7 | 70.0% | ||
| 146-14 | Chimera | +1 bp(T)/−6 bp/−5 bp/−4 bp * | 1 | 10.0% | ||
| Wild type | No mutation | 0 | 0.0% | |||
| Ta161 | Homozygote | Bi-allele | 0 | 0.0% | ||
| 161-1, 161-2, | Homozygote | −4 bp/−4 bp | 9 | 90.0% | ||
|
| Chimera | +1 bp(T)/−6 bp/−5 bp/−4 bp * | 1 | 10.0% | ||
| Wild type | No mutation | 0 | 0.0% | |||
The plant IDs denoted in bold type indicate Cas9-free plants. * Unexpected mutations.
Genetic analysis of CRISPR-Cas9-induced mutations of NbXylT1 in the T0 generation and their transmission to the T1 generation.
| Target Gene: | ||||||
|---|---|---|---|---|---|---|
| T0 Generation | T1 Generation | |||||
| Plant ID | Zygosity | Plant ID | Zygosity | Detected Variation | No. of Plants | Ratio |
| Ta75 | Bi-allele | Bi-allele | +1 bp(A)/−1 bp | 4 | 36.4% | |
| 75-2, 75-12 | Homozygote | −1 bp/−1 bp | 2 | 18.2% | ||
|
| Chimera | +1 bp(T)/−1 bp/+1 bp(A) * | 1 | 9.1% | ||
| wild type | no mutation | 0 | 0.0% | |||
| Ta139 | Bi-allele | 139-1, | Bi-allele | +1 bp(A)/ −1 bp | 3 | 37.5% |
| Homozygote | +1 bp(A)/+1 bp(A) | 3 | 37.5% | |||
| 139-2 | Chimera | +1 bp(A)/+1 bp(T)/ −1 bp * | 1 | 12.5% | ||
| Wild type | WT | 0 | 0.0% | |||
| Ta105 | Bi-allele | Bi-allele | +1 bp(T)/+1 bp(C) | 5 | 50.0% | |
| Homozygote | +1 bp(T)/+1 bp(T) | 1 | 10.0% | |||
|
| Chimera | +1 bp(T)/+1 bp(A)/−1 bp * | 1 | 10.0% | ||
| Wild type | WT | 0 | 0.0% | |||
| Ta106 | Bi-allele | Bi-allele | +1 bp(T)/+1 bp(C) | 3 | 37.5% | |
| Homozygote | +1 bp(T)/+1 bp(T) | 3 | 37.5% | |||
|
| Chimera | +1 bp(A)/+1 bp(T)/+1 bp(C) * | 1 | 12.5% | ||
| Wild type | WT | 0 | 0.0% | |||
| Ta146 | Bi-allele | 146-1, 146-11, 146-12, 146-16, 146-17 | Bi-allele | +1 bp(A)/+1 bp(T) | 5 | 50.0% |
| 146-13 | Homozygote | +1 bp(A)/+1 bp(A) | 1 | 10.0% | ||
| 146-2, 146-14, 146-18 | Chimera | +1 bp(A)/+1 bp(T)/−1 bp * | 3 | 30.0% | ||
| Wild type | WT | 0 | 0.0% | |||
| Ta161 | Bi-allele | Bi-allele | +1 bp(A)/+1 bp(T) | 3 | 30.0% | |
| 161-1, 161-2, 161-12, 161-16, | Homozygote | +1 bp(T)/+1 bp(T) | 5 | 50.0% | ||
|
| Chimera | +1 bp(A)/+1 bp(T)/−1 bp * | 1 | 10.0% | ||
| Wild type | WT | 0 | 0.0% | |||
The plant IDs denoted in bold type indicate Cas9-free plants. * Unexpected mutations.
Analysis of the transmission of homozygous mutant Ta161 for NbXylT1 and NbFucT1 loci from the T1 to T2 generations.
| Generation |
|
| ||||
|---|---|---|---|---|---|---|
| Plant ID | cas9 | Mutation Detected | Mutation Type | Mutation Detected | Mutation Type | |
| T0 plant | Ta161 | + | +1 bp(T)/+1 bp (A) | Bi-allelic | −4 bp/−4 bp | Homozygous |
| T1 plant | Ta161-1 | + | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous |
| T2 plant | Ta161-1-1 | + | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous |
| Ta161-1-2 | − | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-3 | − | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-4 | + | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-5 | + | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-6 | − | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-7 | − | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-8 | + | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-9 | − | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-10 | + | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-11 | + | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-12 | + | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-13 | + | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-14 | − | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-15 | − | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-16 | + | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-17 | − | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-18 | − | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-19 | + | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
| Ta161-1-20 | − | +1 bp(T)/+1 bp (T) | Homozygous | −4 bp/−4 bp | Homozygous | |
+ or − in the Cas9 column indicates the presence or absence of Cas9 in the plant, respectively.